A Review of Therapies for <i>Clostridioides difficile</i> Infection

A Review of Therapies for <i>Clostridioides difficile</i> Infection

<i>Clostridioides difficile</i> is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of <i>Clostridioides difficile</i> infection (CDI), it remains a leading cause...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Faiza Morado, Neha Nanda
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	MDPI AG 2024-12-01
Reeks:	Antibiotics
Onderwerpen:	<i>C. difficile</i> infection recurrent <i>C. difficile</i> infection metronidazole vacomycin fidaxomicin fecal microbiota transplantation
Online toegang:	https://www.mdpi.com/2079-6382/14/1/17

Gelijkaardige items

Controversies in the Prevention and Treatment of <i>Clostridioides difficile</i> Infection in Adults: A Narrative Review
door: Taryn B. Bainum, et al.
Gepubliceerd in: (2023-02-01)

Updated Management Guidelines for <i>Clostridioides difficile</i> in Paediatrics
door: Margherita Gnocchi, et al.
Gepubliceerd in: (2020-04-01)

<i>Clostridioides difficile</i> Infection in an Italian Tertiary Care University Hospital: A Retrospective Analysis
door: Alice Annalisa Medaglia, et al.
Gepubliceerd in: (2023-04-01)

Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study
door: Marcos Hernando-Gozalo, et al.
Gepubliceerd in: (2024-05-01)

Clinical Efficacy of Fidaxomicin and Oral Metronidazole for Treating <i>Clostridioides difficile</i> Infection and the Associated Recurrence Rate: A Retrospective Cohort Study
door: Nobuaki Mori, et al.
Gepubliceerd in: (2023-08-01)

Application of Microbiome Management in Therapy for <i>Clostridioides difficile</i> Infections: From Fecal Microbiota Transplantation to Probiotics to Microbiota-Preserving Antimicrobial Agents
door: Chun-Wei Chiu, et al.
Gepubliceerd in: (2021-05-01)

The Risk of <i>Clostridioides difficile</i> Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
door: Ronald G. Hall, et al.
Gepubliceerd in: (2022-02-01)

<i>Clostridioides difficile</i> infection in hospital and community settings: summary document of a multidisciplinary group
door: Anna Danise, et al.
Gepubliceerd in: (2024-02-01)

Microbiota in <i>Clostridioides difficile</i>-Associated Diarrhea: Comparison in Recurrent and Non-Recurrent Infections
door: Alessandra Gazzola, et al.
Gepubliceerd in: (2020-09-01)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
door: Teena Chopra, et al.
Gepubliceerd in: (2023-01-01)

Efficacy and Safety of Fecal Microbiota Transplantation in Treatment of <i>Clostridioides difficile</i> Infection among Pediatric Patients: A Systematic Review and Meta-Analysis
door: Kyaw Min Tun, et al.
Gepubliceerd in: (2022-12-01)

Insights into the Role of Human Gut Microbiota in <i>Clostridioides difficile</i> Infection
door: Melina Kachrimanidou, et al.
Gepubliceerd in: (2020-01-01)

Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with Clostridioides difficile Infection
door: Hyuk Yoon, et al.
Gepubliceerd in: (2021-01-01)

Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals?
door: Krishna Vedala, et al.
Gepubliceerd in: (2021-06-01)

Iron Effects on <i>Clostridioides difficile</i> Toxin Production and Antimicrobial Susceptibilities
door: Jason Yamaki, et al.
Gepubliceerd in: (2022-04-01)

Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis
door: Hiral N Golakiya, et al.
Gepubliceerd in: (2022-06-01)

Clostridioides difficile infection: a comprehensive review for primary providers
door: Cortés Pedro, et al.
Gepubliceerd in: (2021-09-01)

The Efficacy of Fecal Microbiota Transplantation in Mouse Models Infected with <i>Clostridioides difficile</i> from the Perspective of Metabolic Profiling: A Systematic Review
door: Anna Voziki, et al.
Gepubliceerd in: (2024-12-01)

Fecal Microbiota Transplantation in Patients Co-Infected with SARS-CoV2 and <i>Clostridioides difficile</i>
door: Adrian Boicean, et al.
Gepubliceerd in: (2022-12-01)

Host Immune Responses to <i>Clostridioides difficile</i> Infection and Potential Novel Therapeutic Approaches
door: Md Zahidul Alam, et al.
Gepubliceerd in: (2023-11-01)

Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of <i>Clostridioides difficile</i> Infection
door: Laura Whitney, et al.
Gepubliceerd in: (2023-01-01)

Metronidazole for Treatment of <i>Clostridioides difficile</i> Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality
door: Joana Darc Freitas Alves, et al.
Gepubliceerd in: (2022-08-01)

<i>Clostridioides difficile</i> Infection: Diagnosis and Treatment Challenges
door: John E. Markantonis, et al.
Gepubliceerd in: (2024-01-01)

The Bactericidal Activity and Spore Inhibition Effect of Manuka Honey against <i>Clostridioides Difficile</i>
door: Lillian Yu, et al.
Gepubliceerd in: (2020-10-01)

Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent <named-content content-type="genus-species">Clostridioides difficile</named-content> Infection
door: Danielle Barrios Steed, et al.
Gepubliceerd in: (2020-10-01)

Gut Microbiota Composition Associated with <i>Clostridioides difficile</i> Colonization and Infection
door: Elisa Martinez, et al.
Gepubliceerd in: (2022-07-01)

Is Three Company or a Crowd? Comparing and Contrasting U.S. and European <i>Clostridioides</i><i>difficile</i> Clinical Practice Guidelines
door: Jordan Jones, et al.
Gepubliceerd in: (2022-09-01)

In Silico Analysis of Changes in Predicted Metabolic Capabilities of Intestinal Microbiota after Fecal Microbial Transplantation for Treatment of Recurrent <i>Clostridioides difficile</i> Infection
door: Monica Dahiya, et al.
Gepubliceerd in: (2023-04-01)

Effect of Restriction of Fluoroquinolone Antibiotics on <i>Clostridioides difficile</i> Infections in the University Hospital Hradec Králové
door: Kristýna Vaverková, et al.
Gepubliceerd in: (2021-05-01)

Strong Antimicrobial Effects of Xanthohumol and Beta-Acids from Hops against <i>Clostridioides difficile</i> Infection In Vivo
door: Radek Sleha, et al.
Gepubliceerd in: (2021-04-01)

Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications
door: Nityanand Jain, et al.
Gepubliceerd in: (2023-12-01)

Occurrence of <i>Blastocystis</i> in Patients with <i>Clostridioides difficile</i> Infection
door: Laura Vega, et al.
Gepubliceerd in: (2020-04-01)

Comparative Efficacy of Fecal Microbiota Transplantation in Treating Refractory or Recurrent <i>Clostridioides difficile</i> Infection among Patients with and without Inflammatory Bowel Disease: A Retrospective Cohort Study
door: Jing-Han Chen, et al.
Gepubliceerd in: (2024-06-01)

Biofilm Formation of <i>Clostridioides difficile</i>, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI
door: Leon M. T. Dicks
Gepubliceerd in: (2023-08-01)

Treatment of pediatric Clostridium difficile infection: a review on treatment efficacy and economic value
door: D'Ostroph AR, et al.
Gepubliceerd in: (2017-10-01)

Investigation of Intestinal Microbiota and Fecal Calprotectin in Non-Toxigenic and Toxigenic <i>Clostridioides difficile</i> Colonization and Infection
door: Sung-Hee Han, et al.
Gepubliceerd in: (2020-06-01)

High Prevalence of <i>Clostridioides difficile</i> Ribotype 176 in the University Hospital in Kosice
door: Katarina Curova, et al.
Gepubliceerd in: (2023-03-01)

Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of <i>Clostridioides difficile</i> Infections
door: Lynne V. McFarland, et al.
Gepubliceerd in: (2023-06-01)

Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing <i>Clostridioides difficile</i> Infection
door: Khalid Alyahya, et al.
Gepubliceerd in: (2023-06-01)

Review of the Impact of Biofilm Formation on Recurrent <i>Clostridioides difficile</i> Infection
door: Daira Rubio-Mendoza, et al.
Gepubliceerd in: (2023-10-01)